1. Home
  2. RCEL vs CIO Comparison

RCEL vs CIO Comparison

Compare RCEL & CIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • CIO
  • Stock Information
  • Founded
  • RCEL N/A
  • CIO 2013
  • Country
  • RCEL United States
  • CIO Canada
  • Employees
  • RCEL N/A
  • CIO N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • CIO Real Estate Investment Trusts
  • Sector
  • RCEL Health Care
  • CIO Real Estate
  • Exchange
  • RCEL Nasdaq
  • CIO Nasdaq
  • Market Cap
  • RCEL 170.8M
  • CIO 202.0M
  • IPO Year
  • RCEL N/A
  • CIO 2014
  • Fundamental
  • Price
  • RCEL $5.62
  • CIO $4.88
  • Analyst Decision
  • RCEL Strong Buy
  • CIO
  • Analyst Count
  • RCEL 4
  • CIO 0
  • Target Price
  • RCEL $17.25
  • CIO N/A
  • AVG Volume (30 Days)
  • RCEL 347.9K
  • CIO 137.4K
  • Earning Date
  • RCEL 05-08-2025
  • CIO 05-02-2025
  • Dividend Yield
  • RCEL N/A
  • CIO 8.20%
  • EPS Growth
  • RCEL N/A
  • CIO N/A
  • EPS
  • RCEL N/A
  • CIO N/A
  • Revenue
  • RCEL $71,661,000.00
  • CIO $168,891,000.00
  • Revenue This Year
  • RCEL $59.50
  • CIO $1.76
  • Revenue Next Year
  • RCEL $28.89
  • CIO $3.60
  • P/E Ratio
  • RCEL N/A
  • CIO N/A
  • Revenue Growth
  • RCEL 41.35
  • CIO N/A
  • 52 Week Low
  • RCEL $5.46
  • CIO $4.19
  • 52 Week High
  • RCEL $14.16
  • CIO $6.50
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 25.54
  • CIO 49.80
  • Support Level
  • RCEL $6.06
  • CIO $4.62
  • Resistance Level
  • RCEL $6.38
  • CIO $4.99
  • Average True Range (ATR)
  • RCEL 0.47
  • CIO 0.13
  • MACD
  • RCEL -0.11
  • CIO 0.00
  • Stochastic Oscillator
  • RCEL 8.12
  • CIO 55.60

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About CIO City Office REIT Inc.

City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. The company owns office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.

Share on Social Networks: